PRESS-RELEASE

URALCHEM, OJSC announces reorganization

Moscow – 26 July, 2010 – As part of the transfer to a single stock URALCHEM, OJSC announces that it launched reorganization of URALCHEM Group companies. On 23 July, 2010 the Board of Directors of URALCHEM, OJSC resolved to convene an extraordinary general meeting of the Company’s shareholders to consider reorganization. The Board of Directors of URALCHEM, OJSC recommended that the general shareholders’ meeting resolve to reorganize the Company by merging Azot, OJSC and URALCHEM Management Company, and approve the respective Merger Contracts.

In order to resolve on merger with URALCHEM, OJSC the companies that take part in the merger will hold extraordinary general meetings of shareholders in the beginning of September 2010.

Dmitry Osipov, the Chief executive Officer of URALCHEM, OJSC commented: “The proposed merger will allow us to improve financial flows management in the Group and significantly decrease administrative and management costs. In addition, reorganization will make the Group more attractive as an investment”.

In future, Uralchem plans to merge other Group companies with URALCHEM, OJSC.

Public Relations Department
Uralchem, OJSC
tel. +7 (495) 721 89 89
pr@uralchem.com
www.uralchem.com

URALCHEM is one of the largest companies in the nitrogen and phosphate fertilizer markets in Russia and the CIS with annual production capacities of over 2.5 million tonnes of ammonium nitrate, 2.2 million tonnes of ammonia, 0.8 million tonnes of MAP and DAP, 0.8 million tonnes of compound fertilizers and 0.5 million tonnes of urea. URALCHEM is the second largest ammonium nitrate producer in the world and number one in Russia. URALCHEM’s key production assets include Kirovo-Chepetsk Chemical Works, OJSC in Kirovo-Chepetsk, Kirov region; Azot, OJSC in Berezniki, Perm region; Voskresensk Mineral Fertilizers, OJSC in Voskresensk, Moscow region.

Some of the information in this press release may contain projections or other forward-looking statements regarding future events or the future financial performance of URALCHEM. We wish to caution you that these statements are only predictions. We do not intend to update these statements and our actual results may differ materially from those contained in our projections or forward-looking statements, including, among others, the achievement of anticipated levels of profitability, growth, cost and synergy of our recent acquisitions, the impact of competitive pricing, the ability to obtain necessary regulatory approvals and licenses, the impact of developments in the Russian economic, political and legal environment, financial risk management and the impact of general business and global economic conditions.